{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:20:34Z","timestamp":1782451234932,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bpa.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:41:32Z","timestamp":1593808892000},"page":"355-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The utilization of buprenorphine in chronic pain"],"prefix":"10.1016","volume":"34","author":[{"given":"Ivan","family":"Urits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Berardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudhvi","family":"Bandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariunzaya","family":"Amgalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmaiah","family":"Manchikanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2020.06.005_bib1","first-page":"996","article-title":"Long-term consequences of chronic pain: mounting evidence for pain as a Neurological disease and parallels with other chronic disease states","volume":"vol. 12","author":"Fine","year":"2011"},{"key":"10.1016\/j.bpa.2020.06.005_bib2","first-page":"510","article-title":"Persistent pain as a disease entity: implications for clinical management","volume":"vol. 99","author":"Siddall","year":"2004"},{"issue":"3","key":"10.1016\/j.bpa.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1533-2500.2004.04301.x","article-title":"Chronic pain as a disease in its own right","volume":"4","author":"Niv","year":"2004","journal-title":"Pain Pract"},{"key":"10.1016\/j.bpa.2020.06.005_bib4","first-page":"1284","article-title":"Is chronic pain a disease?","volume":"vol. 14","author":"Cohen","year":"2013"},{"key":"10.1016\/j.bpa.2020.06.005_bib5","first-page":"263","volume":"vol. 43","author":"Pearce","year":"2005"},{"issue":"12","key":"10.1016\/j.bpa.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.pain.2013.08.003","article-title":"The words patients use to describe chronic pain: implications for measuring pain quality","volume":"154","author":"Jensen","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib7","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1172\/JCI43766","article-title":"Central modulation of pain","volume":"120","author":"Ossipov","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpa.2020.06.005_bib8","first-page":"1113","article-title":"How neuroimaging studies have challenged us to rethink: is chronic pain a disease?","volume":"vol. 10","author":"Tracey","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"vol. 152","author":"Woolf","year":"2011","journal-title":"Pain"},{"issue":"43","key":"10.1016\/j.bpa.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"14874","DOI":"10.1523\/JNEUROSCI.1733-12.2012","article-title":"Pain and plasticity: is chronic pain always associated with somatosensory cortex activity and reorganization?","volume":"32","author":"Gustin","year":"2012","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-352","article-title":"Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population - a cross-sectional survey","volume":"14","author":"H\u00e4user","year":"2014","journal-title":"BMC Publ Health"},{"issue":"10","key":"10.1016\/j.bpa.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3899\/jrheum.141328","article-title":"Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic pain","volume":"42","author":"Taylor","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.bpa.2020.06.005_bib13","first-page":"88","article-title":"Pain","volume":"vol. 160","author":"Nugraha","year":"2019"},{"issue":"10","key":"10.1016\/j.bpa.2020.06.005_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224084","article-title":"Epidemiology of chronic pain in Ukraine: findings from the world mental health survey","volume":"14","author":"Xu","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.bpa.2020.06.005_bib15","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.bpa.2020.06.005_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejpain.2005.08.004","article-title":"Expectancy, fear and pain in the prediction of chronic pain and disability: a prospective analysis","volume":"10","author":"Boersma","year":"2006","journal-title":"Eur J Pain"},{"issue":"10","key":"10.1016\/j.bpa.2020.06.005_bib17","first-page":"883","article-title":"Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders","volume":"9","author":"Tsang","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/fampra\/cmi078","article-title":"Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland\u2014an observational study","volume":"23","author":"Busato","year":"2006","journal-title":"Fam Pract"},{"issue":"12","key":"10.1016\/j.bpa.2020.06.005_bib19","first-page":"1459","article-title":"Racial and socioeconomic disparities in disabling chronic pain: findings from the health and retirement study","volume":"18","author":"Janevic","year":"2017","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9815750","article-title":"An epidemiological study of neuropathic pain symptoms in Canadian adults","volume":"2016","author":"VanDenKerkhof","year":"2016","journal-title":"Pain Res Manag"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/2049463715569806","article-title":"Can large surveys conducted on highly selected populations provide valid information on the epidemiology of common health conditions? An analysis of UK Biobank data on musculoskeletal pain","volume":"9","author":"Macfarlane","year":"2015","journal-title":"Br J Pain"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12971-015-0042-y","article-title":"Prevalence of smoking in adults with chronic pain","volume":"13","author":"Orhurhu","year":"2015","journal-title":"Tob Induc Dis"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib23","first-page":"944","article-title":"Self-report of alcohol use for pain in a multi-ethnic community sample","volume":"10","author":"Riley","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib24","article-title":"Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews","volume":"vol. 2017","author":"Geneen","year":"2017"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40122-015-0036-8","article-title":"Vitamin D deficiency and pain: clinical evidence of low levels of vitamin D and supplementation in chronic pain states","volume":"4","author":"Shipton","year":"2015","journal-title":"Pain Ther"},{"issue":"9836","key":"10.1016\/j.bpa.2020.06.005_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/j.pain.0000000000001133","article-title":"Pain as a risk factor for common mental disorders. Results from The Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study","volume":"159","author":"De Heer","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib28","first-page":"29","article-title":"An overview of treatment approaches for chronic pain management","volume":"vol. 37","author":"Hylands-White","year":"2017"},{"issue":"22","key":"10.1016\/j.bpa.2020.06.005_bib29","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","article-title":"The comparative safety of opioids for nonmalignant pain in older adults","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpa.2020.06.005_bib30","series-title":"Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review","volume":"2012","author":"Roman\u00f2","year":"2012"},{"issue":"7","key":"10.1016\/j.bpa.2020.06.005_bib31","first-page":"CD010958","article-title":"Topical lidocaine for neuropathic pain in adults","volume":"2014","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpa.2020.06.005_bib32","first-page":"66","article-title":"Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review","volume":"vol. 23","author":"Urits","year":"2019"},{"issue":"3 Suppl Spine","key":"10.1016\/j.bpa.2020.06.005_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3171\/spi.2004.100.3.0254","article-title":"Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review","volume":"100","author":"Cameron","year":"2004","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.bpa.2020.06.005_bib34","first-page":"490","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 patch","volume":"vol. 107","author":"Anand","year":"2011"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-015-0517-9","article-title":"Psychological interventions for the management of chronic pain: a review of current evidence","volume":"19","author":"Kaiser","year":"2015","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2020.06.005_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/PRBM.S44762","article-title":"Psychology research and behavior management dovepress psychological therapies for the management of chronic pain","volume":"7","author":"Sturgeon","year":"2014","journal-title":"Psychol Res Behav Manag"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib37","first-page":"55","article-title":"Management of chronic pain through pain management programmes","volume":"124","author":"Wilson","year":"2017","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","article-title":"A\u00a0narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain","volume":"9","author":"Fudin","year":"2020","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.bpa.2020.06.005_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Pract"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib41","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2016.38","article-title":"Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors","volume":"41","author":"Falcon","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/pm\/pnx321","article-title":"The pharmacokinetics and local tolerability of a novel sublingual formulation of buprenorphine","volume":"20","author":"Chin Beng Lim","year":"2019","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.bpa.2020.06.005_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clinthera.2015.12.016","article-title":"Evaluation of the pharmacokinetics of single- and multiple-dose buprenorphine buccal film in healthy volunteers","volume":"38","author":"Bai","year":"2016","journal-title":"Clin Therapeut"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/03639045.2013.846365","article-title":"Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine\/naloxone tablet formulation in healthy volunteers","volume":"41","author":"Fischer","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib45","first-page":"417","article-title":"Buprenorphine for opioid dependence","volume":"9","author":"Gordon","year":"2013","journal-title":"Interv Addict"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib46","first-page":"1573","article-title":"Managing opioid addiction with buprenorphine","volume":"73","author":"Donaher","year":"2006","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.bpa.2020.06.005_bib47","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ajem.2019.05.053","article-title":"Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder","volume":"37","author":"Herring","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3554-6","article-title":"A\u00a0randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving","volume":"20","author":"Ahmadi","year":"2019","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.bpa.2020.06.005_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-018-0732-2","article-title":"Buprenorphine for chronic pain: a systemic review","volume":"22","author":"Fishman","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2020.06.005_bib50","first-page":"1211","volume":"vol. 78","author":"Davis","year":"2018"},{"issue":"5","key":"10.1016\/j.bpa.2020.06.005_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14737175.2018.1462701","article-title":"Transdermal buprenorphine for moderate chronic noncancer pain syndromes","volume":"18","author":"Pergolizzi","year":"2018","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.bpa.2020.06.005_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aat.2015.06.001","article-title":"The unique role of transdermal buprenorphine in the global chronic pain epidemic","volume":"53","author":"Pergolizzi","year":"2015","journal-title":"Acta Anaesthesiol Taiwanica"},{"issue":"2","key":"10.1016\/j.bpa.2020.06.005_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40122-019-0126-0","article-title":"Pain control in Latin America: the optimized role of buprenorphine in the treatment of cancer and noncancer pain","volume":"8","author":"Pergolizzi","year":"2019","journal-title":"Pain Ther"},{"key":"10.1016\/j.bpa.2020.06.005_bib54","series-title":"Belbuca (buprenorphine buccal film) package insert","year":"2019"},{"key":"10.1016\/j.bpa.2020.06.005_bib55","series-title":"Butrans (buprenorphine transdermal system) package insesrt","author":"Purdue Pharma","year":"2014"},{"key":"10.1016\/j.bpa.2020.06.005_bib56","series-title":"Buprenorphine for chronic pain: a review of the clinical effectiveness","first-page":"1","author":"Cadth","year":"2017"},{"issue":"12","key":"10.1016\/j.bpa.2020.06.005_bib57","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/pme.12520","article-title":"Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","volume":"15","author":"Daitch","year":"2014","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00325481.2016.1128307","article-title":"Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain","volume":"128","author":"Rauck","year":"2016","journal-title":"Postgrad Med"},{"issue":"11","key":"10.1016\/j.bpa.2020.06.005_bib59","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/j.pain.0000000000000670","article-title":"Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study","volume":"157","author":"Gimbel","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.06.005_bib60","first-page":"233","article-title":"Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids","volume":"10","author":"Hale","year":"2017","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00325481.2017.1267537","article-title":"Buprenorphine transdermal system utilization","volume":"129","author":"Wallace","year":"2017","journal-title":"Postgrad Med"},{"issue":"3","key":"10.1016\/j.bpa.2020.06.005_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/papr.12281","article-title":"Buprenorphine transdermal system improves sleep quality and reduces sleep disturbance in patients with moderate-to-severe chronic low back pain: results from two randomized controlled trials","volume":"16","author":"Yarlas","year":"2016","journal-title":"Pain Pract"},{"issue":"5","key":"10.1016\/j.bpa.2020.06.005_bib63","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","article-title":"Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase","volume":"32","author":"Gordon","year":"2010","journal-title":"Clin Therapeut"},{"issue":"6","key":"10.1016\/j.bpa.2020.06.005_bib64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jpainsymman.2011.04.006","article-title":"Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-Na\u00efve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study","volume":"42","author":"Steiner","year":"2011","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/00325481.2014.992715","article-title":"Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain","volume":"127","author":"Yarlas","year":"2015","journal-title":"Postgrad Med"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib66","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2337\/dc16-0123","article-title":"Transdermal buprenorphine relieves neuropathic pain: a randomized, double-blind, parallel-group, placebo-controlled trial in diabetic peripheral neuropathic pain","volume":"39","author":"Simpson","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-017-1664-4","article-title":"Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain","volume":"18","author":"Yoon","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"10.1016\/j.bpa.2020.06.005_bib68","first-page":"1009","article-title":"A\u00a0novel application of buprenorphine transdermal patch to relieve pain in the knee joint of knee osteoarthritis patients: a retrospective case-control study","volume":"8","author":"Gil","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40271-015-0151-y","article-title":"Assessment of transdermal buprenorphine patches for the treatment of chronic pain in a UK observational study","volume":"9","author":"Serpell","year":"2016","journal-title":"Patient"},{"issue":"6","key":"10.1016\/j.bpa.2020.06.005_bib70","first-page":"577","article-title":"The clinical analgesic efficacy of buprenorphine","volume":"39","author":"Raffa","year":"2014","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40271-016-0181-0","article-title":"Satisfaction, adherence and health-related quality of life with transdermal buprenorphine compared with oral opioid medications in the usual care of osteoarthritis pain","volume":"9","author":"Conaghan","year":"2016","journal-title":"Patient - Patient-centered Outcomes Res"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/pme.12011","article-title":"A\u00a0feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent noncancer pain","volume":"14","author":"Mitra","year":"2013","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.bpa.2020.06.005_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1185\/03007995.2012.678938","article-title":"Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain","volume":"28","author":"Wolff","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"C","key":"10.1016\/j.bpa.2020.06.005_bib74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sjpain.2014.07.002","article-title":"Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights","volume":"6","author":"Norrlid","year":"2015","journal-title":"Scand J Pain"},{"issue":"11","key":"10.1016\/j.bpa.2020.06.005_bib75","first-page":"1163","article-title":"Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study","volume":"12","author":"Steiner","year":"2011","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.bpa.2020.06.005_bib76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14740338.2013.780025","article-title":"Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis","volume":"12","author":"Wen","year":"2013","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.bpa.2020.06.005_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00325481.2017.1270699","article-title":"Safety of buprenorphine transdermal system in the management of pain in older adults","volume":"129","author":"Pergolizzi","year":"2017","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.bpa.2020.06.005_bib78","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/pm\/pnv110","article-title":"Evaluation of the tolerability of switching patients on chronic full \u03bc-opioid agonist therapy to buccal buprenorphine","volume":"17","author":"Webster","year":"2016","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.bpa.2020.06.005_bib79","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/pme.12142","article-title":"Dose Patterns among patients using low-dose buprenorphine patches","volume":"14","author":"Les\u00e9n","year":"2013","journal-title":"Pain Med"},{"issue":"February","key":"10.1016\/j.bpa.2020.06.005_bib80","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jcph.718","article-title":"Dose-dependent flux of buprenorphine following transdermal administration in healthy subjects","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.bpa.2020.06.005_bib81","first-page":"44","article-title":"Rapid induction of buprenorphine\/naloxone for chronic pain using a microdosing regimen","volume":"14","author":"Lee","year":"2020","journal-title":"In Pract"},{"issue":"4","key":"10.1016\/j.bpa.2020.06.005_bib82","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding buprenorphine for use in chronic pain: expert opinion","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152168962030046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152168962030046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:29:16Z","timestamp":1776425356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152168962030046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S152168962030046X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.06.005","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utilization of buprenorphine in chronic pain","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}